Market Overview

Benzinga's Top #PreMarket Gainers

Related PATH
Benzinga's M&A Chatter for Tuesday January 21, 2014
Teva Acquires NuPathe for $3.65/Share in Cash, Plus Up to $3.15/Share Based on Zecuity Sales
Related ENDP
5 Biggest Price Target Changes For Wednesday
28 Stocks Moving In Monday's Pre-Market Session

NuPathe (NASDAQ: PATH) surged 50.43% to $3.46 in the pre-market session after the company agreed to be acquired by Endo Health Solutions (NASDAQ: ENDP) for $2.85 per share in cash.

Solta Medical (NASDAQ: SLTM) soared 21.05% to $2.53 in the pre-market trading after Valeant Pharmaceuticals (NYSE: VRX) agreed to acquire Solta Medical for $2.92 per share in cash.

AcelRx Pharmaceuticals (NASDAQ: ACRX) shares jumped 9.15% to $8.95 in pre-market trading after the company announced the collaboration for EU commercialization of ZALVISO.

YRC Worldwide (NASDAQ: YRCW) shares gained 3.28% to $12.90 in the pre-market. YRC Worldwide shares have jumped 81.28% over the past 52 weeks, while the S&P 500 index has gained 24.12% in the same period.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (ENDP + ACRX)

View Comments and Join the Discussion!